NAV3 and ovarian cancer: Other neurotransmitters, such as NAV3, also localized to OSEs and sometimes gonadal interstitium; notably, epitranscriptomic downregulation of this gene has been implicated in chemotherapy resistance in ovarian cancer, suggesting a possible role of these primitive neuroactive pathways within oncogenesis in later life60.